New portable device can detect diabetes, kidney failure, chronic anemia, malnutrition

New portable device can detect diabetes, kidney failure, chronic anemia, malnutrition


Bangalore-based PathShodh Healthcare, a startup at the Entrepreneurship Centre of the Indian Institute of Science, has developed a hand-held device to measure eight vital parameters for diabetes, kidney failure, chronic anaemia, and malnutrition.

The device, called anuPath, has been developed by Dr. Vinay Kumar along with Professor Navakanta Bhat of Indian Institute of Science and a friend, Gautam Sharma.

According to a recent International Diabetes Federation (IDF) report, diabetes currently affects over 425 million people worldwide, and the figure is expected to reach 629 million by 2045. With 73 million diabetics, India ranks second in the world after China.

People with diabetes have an increased risk of developing a number of serious health problems. Consistently high blood glucose levels can lead to serious diseases affecting the heart and blood vessels, eyes, kidneys, nerves and teeth. In addition, people with diabetes also have a higher risk of developing infections, says the IDF report.

Currently, anuPath can test for hemoglobin, HbA1C, glycated albumin, blood glucose, serum albumin, microalbuminuria, urine ACR, and urine creatinine. It will be extendable to other markers (glycated albumin, serum creatinine, serum bilirubin, etc.) in the future. It works on a non-enzymatic- and non-antibody-based electrochemical biosensing technology. The measurement is done on electrochemical disposable test strips that contain a membrane infused with patented sensing substances. For each biomarker there is a separate disposable strip. When the user places the required sample on the electrochemical disposable test strip, anuPath detects the electrochemical outcomes and the deciphered results are displayed on the digital monitor within a minute. This enables the patient to get a comprehensive report of the status of the disease, which is essential in disease management. Read full research paper.

Presently, it can store one lakh patient reports, making it easier to share with doctors. With one international patent and eight in process, anuPath costs Rs. 50,000. The team is working on a cost effective model of about Rs. 5,000 – Rs. 10,000 for individual users to use it at home. Read more

Scientists convert hazardous medical waste to useful material

Scientists convert hazardous medical waste to useful material


A team of scientists at the National Chemical Laboratory, Pune, and the Institute of Chemical Technology, Mumbai, has developed a non-toxic technique to recycle plaster of Paris (PoP) waste from hospitals and convert it into useful materials such as ammonium sulphate and calcium bicarbonate.

In hospitals and other medical centers PoP is mainly used for setting broken or fractured bones or for making casts in dentistry. It is a hazardous waste, loaded with bacteria, and affects not only the environment, but also people who collect, segregate, and dispose it.

The new technique treats PoP waste with ammonium bicarbonate solution with a concentration of 20 percent. The solution disintegrates the waste into high value and non-toxic chemicals, ammonium sulphate and calcium bicarbonate in the form of sludge in 24-36 hours at room temperature.

The resultant material ammonium sulphate can be utilized as nitrogen fertilizer, fire-extinguishing powder, and in pharmaceutical, textile, and wood pulp industries, while calcium carbonate can be easily used in steel manufacturing.

The new technique can also be used to disintegrate PoP waste from idols immersed in water bodies.

The study results have been published in the International Journal of Environmental Science and TechnologyRead the full report by Vaishali Lavekar.

Health-Care Industry Mines Networking Data

Health-Care Industry Mines Networking Data


MedNetworks, a startup that grew out of the Harvard lab of sociologist and physician Nicholas Christakis, is mining anonymized medical-claims data to identify which doctors may be the strongest influencers of their colleagues. The company uses computational tools developed at Christakis’s lab to look at the prescribing patterns of large groups of doctors, build maps of professional ties, and track how the popularity of a new drug grows.  Read more